SLP (Simulations Plus) Current Deferred Revenue: $5.28 Mil (As of May. 2026)


SLP Simulations Plus Inc SLP
85 GF Score
Price $18.28
GF Value $35.40
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Simulations Plus Current Deferred Revenue?

Simulations Plus SLP +0.16% 85 Current Deferred Revenue is $5.28 Mil as of May. 2026. GuruFocus rates SLP with a GF Score™ of 85/100 and a GF Value™ of $35.40 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Simulations Plus's current deferred revenue for the quarter that ended in May. 2026 was $5.28 Mil.

Simulations Plus Current Deferred Revenue Related Terms

Simulations Plus Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Simulations Plus's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Simulations Plus Current Deferred Revenue Chart

Simulations Plus Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 2.86 3.10 2.00 2.70

Simulations Plus Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.34 2.70 5.72 5.53 5.28
SLP
85GF Score
Simulations Plus Inc SLP
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of $5.28 Mil mean?
Simulations Plus (SLP) has a Current Deferred Revenue of $5.28 Mil as of May. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Simulations Plus and its competitors.
Is Simulations Plus' Current Deferred Revenue too high?
Simulations Plus' current Current Deferred Revenue is $5.28 Mil. Overall, Simulations Plus has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Simulations Plus' Current Deferred Revenue compare to TBRG and CARL?
Simulations Plus' Current Deferred Revenue of $5.28 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Simulations Plus and its competitors. Simulations Plus's current Current Deferred Revenue is $5.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simulations Plus stock overvalued right now?
Based on GuruFocus' analysis, Simulations Plus (SLP) is currently considered Significantly Undervalued. The stock's GF Value™ is $35.40, compared to a current price of $18.28 — trading 48.4% below its estimated fair value. The current Current Deferred Revenue is $5.28 Mil. Simulations Plus' overall GF Score™ is 85/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Simulations Plus (SLP), the current Current Deferred Revenue is $5.28 Mil as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Simulations Plus (SLP) Overvalued in 2026?

Based on GuruFocus' analysis, Simulations Plus stock appears to be undervalued. The current stock price of $18.28 is trading 48.4% below its estimated GF Value™ of $35.40. GuruFocus considers Simulations Plus to be Significantly Undervalued.

Key valuation signals for SLP:

  • Current Deferred Revenue: $5.28 Mil
  • GF Value™: $35.40 vs. price of $18.28 (48.4% below fair value)
  • GF Score™: 85/100 with 7 warning signs

No single metric tells the full story. See the SLP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Simulations Plus Business Description

Other Exchanges SD3:Germany
Address 800 Park Offices Drive, Suite 401, Research Triangle Park, Lancaster, NC, USA, 27709
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
85GF Score

Get the complete analysis for SLP

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.28
Price
$35.40
GF Value